Latham BioPharm Group services

Understanding and navigating the non-dilutive funding landscape can be a complex endeavor, but obtaining the funding can be very rewarding.  Our team has specialized domain expertise and understands the U.S. government funding priorities as they relate to the development of new life sciences products.  We have strategic relationships with personnel within the U.S. government and other non-dilutive funding entities, and our expertise and core network can be leveraged to position your organization to receive funding.

Our team has comprehensive capabilities to support your efforts to submit compliant white papers and full proposals in response to non-dilutive funding solicitations. We can help with the entire process, including managing and organizing team members, supporting proposal schedule planning, and writing and reviewing for compliance. This includes full capabilities to support both the technical and business elements of a proposal effort.  Moreover, we become fully engaged and become a functioning member of your team.

We offer comprehensive end-to-end process support for your CMC efforts–from early development and optimization endeavors, to progressing through scale-up during advanced development, to supporting your end commercial process. Consider us your trusted CMC partner throughout the entire process. Our consultants each have an average of more than 20 years of experience in the Pharma industry, from Development, Operations, Technical Services, Quality Assurance, Quality Control, Compliance, and Auditing. We provide expertise in formulation and design, process optimization, scale-up, technical transfer, CDMO selection/management, technical design, fill/finish, and protocol review, and our experience spans API, Drug Substance, and Drug Product activities.